Prospective Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of ACTLINK Plasma Treatment for Promoting Osseointegration and Bone Regeneration in Dental Implants.

MLA

Kwon, Jin-Seon, et al. “Prospective Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of ACTLINK Plasma Treatment for Promoting Osseointegration and Bone Regeneration in Dental Implants.” Bioengineering (Basel), vol. 11, no. 10, Oct. 2024, p. 980. EBSCOhost, https://doi.org/10.3390/bioengineering11100980.

APA

Kwon, J.-S., Cho, W.-T., Lee, J.-H., Joo, J.-Y., Lee, J.-Y., Lim, Y., Jeon, H.-J., & Huh, J.-B. (2024). Prospective Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of ACTLINK Plasma Treatment for Promoting Osseointegration and Bone Regeneration in Dental Implants. Bioengineering (Basel), 11(10), 980. https://doi.org/10.3390/bioengineering11100980

Chicago

Kwon, Jin-Seon, Won-Tak Cho, Jong-Ho Lee, Ji-Young Joo, Jae-Yeol Lee, Youbong Lim, Hyun-Jeong Jeon, and Jung-Bo Huh. 2024. “Prospective Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of ACTLINK Plasma Treatment for Promoting Osseointegration and Bone Regeneration in Dental Implants.” Bioengineering (Basel) 11 (10): 980. doi:10.3390/bioengineering11100980.